Drugs for Lambert-Eaton Myasthenic Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 45)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Racephedrine |
Approved, Experimental |
Phase 1, Phase 2 |
|
299-42-3, 90-82-4, 90-81-3 |
5032 9294 7028 |
Synonyms:
(-)-Ephedrine
(+) Threo-2-(methylamino)-1-phenyl-1-propanol
(+)-(1S,2S)-Pseudoephedrine
(+-)-Ephedrine
(+)-Pseudoephedrine
(+)-Psi-ephedrine
(+)-Threo-ephedrine
(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane
(1S,2S)-(+)-Pseudoephedrine
(1S,2S)-Pseudoephedrine
1-Ephedrine
2-(Methylamino)-1-phenyl-1-propanol
Acunaso
Besan
D-Isoephedrine
D-Pseudoephedrine
D-Pseudoephedrine base
D-Psi-2-methylamino-1-phenyl-1-propanol
D-Psi-ephedrine
Efedrina
Emerphed® (ephedrine sulfate injection)
Ephedrine
Ephedrine DL-form
Ephedrine erythro isomer
Ephedrine hydrochloride
Ephedrine renaudin
Ephedrine sulfate
Ephedrine threo isomer
Erythro isomer OF ephedrine
Hydrochloride, ephedrine
Isoephedrine
L(-)-Ephedrine
L(−)-EPHEDRINE
|
L-(+)-Pseudoephedrine
L(+)-Psi-ephedrine
L-Ephedrine
L-Erythro-2-(methylamino)-1-phenylpropan-1-ol
Neodurasina
Novafed
NSC-170951
NSC-8971
Pseudoefedrina
Pseudoephedrine
pseudoéphédrine
Pseudoephedrine D-form
Pseudoephedrine ephedrine
Pseudoephedrine HCL
Pseudoephedrine hydrochloride
Pseudoephedrinum
PSEUDOPHEDRINE SULPHATE
Psi-ephedrin
Psi-ephedrine
Racephedrine
Renaudin brand OF ephedrine hydrochloride
Renaudin, ephedrine
Sal phedrine
Sal-phedrine
SalPhedrine
SINUTAB
Sudafed
Sulfate, ephedrine
Threo isomer OF ephedrine
trans-Ephedrine
Wendt brand OF ephedrine sulfate
ψ-ephedrine
|
|
2 |
|
Melphalan |
Approved |
Phase 2 |
|
148-82-3 |
4053 460612 |
Synonyms:
2-Amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoate
2-Amino-3-{4-[bis(2-chloroethyl)amino]phenyl}propanoate
3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine
3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine
4-(Bis(2-chloroethyl)amino)-L-phenylalanine
4-(Bis(2-chloroethyl)amino)phenylalanine
AIKERAN
ALANINE NITROGEN MUSTARD
Alkeran
CB-3025
L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine
Levofalan
L-PAM
L-Phenylalanine mustard
L-PHENYLALANINE MUSTARD (L-PAM)
L-SARCOLYSIN
L-Sarcolysine
L-Sarkolysin
Medphalan
MELFALAN
Melfalano
Melphalan
|
Melphalanum
Mephalan
Merphalan
MLP673
Mustard, phenylalanine
NCI-C04853
NSC-241286
NSC-8806
p-Bis(b-chloroethyl)aminophenylalanine
p-Bis(beta-chloroethyl)aminophenylalanine
p-Bis(β-chloroethyl)aminophenylalanine
p-Di-(2-chloroethyl)amino-L-phenylalanine
Phenylalanine mustard
Phenylalanine nitrogen mustard
p-L-Sarcolysin
p-N,N-Bis(2-chloroethyl)amino-L-phenylalanine
p-N-Bis(2-chloroethyl)amino-L-phenylalanine
Sarcolysin
Sarcolysine
Sarkolysin
SK 15673
SK-15673
|
|
3 |
|
Carmustine |
Approved, Investigational |
Phase 2 |
|
154-93-8 |
2578 |
Synonyms:
1,3-Bis(2-chloroethyl)-1-nitrosourea
BCNU
Bicnu
BICNU (TN)
Bischlorethylnitrosourea
Bischlorethylnitrosurea
Bischloroethyl nitrosourea
BIS-CHLOROETHYLNITROSOUREA
Carmustin
Carmustina
CARMUSTINE
|
Carmustinum
CARUSTINE
DTI-015
FDA-0345
FIVB
Gliadel
N,N'-bis(2-chloroethyl)-N-nitrosourea
Nitrumon
NSC-409962
SK-27702
SRI-1720
|
|
4 |
|
Etoposide |
Approved |
Phase 2 |
|
33419-42-0 |
36462 |
Synonyms:
(-)-Etoposide
(−)-ETOPOSIDE
(-)-etoposide|Etopophos®|Toposar®|trans-etoposide|VePesid®|VP 16-213|VP-16
4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-b-D-glucopyranoside)
4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)
4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-β-D-glucopyranoside)
4-Demethylepipodophyllotoxin b-D-ethylideneglucoside
4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside
4-Demethylepipodophyllotoxin β-D-ethylideneglucoside
9-((4,6-O-Ethylidine-b-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one
9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one
9-((4,6-O-Ethylidine-β-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one
alpha-D-Glucopyranosyl isomer etoposide
Baxter brand OF etoposide
Baxter oncology brand OF etoposide
Bristol myers brand OF etoposide
Bristol myers squibb brand OF etoposide
Bristol-myers brand OF etoposide
Bristol-myers squibb brand OF etoposide
Celltop
Demethyl epipodophyllotoxin ethylidine glucoside
Eposide
Eposin
Eto gry
Eto-gry
Etomedac
Etopophos
Etopos
ETOPOSIDE
Etoposide pierre fabre
Etoposide teva
Etoposide, (5a alpha)-isomer
Etoposide, (5a alpha,9 alpha)-isomer
Etoposide, (5S)-isomer
Etoposide, alpha D glucopyranosyl isomer
|
Etoposide, alpha-D-glucopyranosyl isomer
Etoposido
Etoposido ferrer farma
Etoposidum
Etoposidum [INN-Latin]
Exitop
Ferrer brand OF etoposide
Gry brand OF etoposide
Lastet
Lemery brand OF etoposide
Medac brand OF etoposide
Novartis brand OF etoposide
NSC-141540
Onkoposid
Onkoworks brand OF etoposide
Pharmachemie brand OF etoposide
Pierre fabre brand OF etoposide
Prasfarma brand OF etoposide
Riboposid
Ribosepharm brand OF etoposide
Sanfer brand OF etoposide
Tedec meiji brand OF etoposide
Teva brand OF etoposide
Teva, etoposide
Toposar
trans-Etoposide
Vepesid
Vepesid J
Vépéside sandoz
Vépéside-sandoz
VP 16
VP 16-213
VP-16
VP-16-213
Zuyeyidal
|
|
5 |
|
Picropodophyllin |
Approved, Investigational |
Phase 2 |
|
518-28-5, 477-47-4 |
10607 72435 |
Synonyms:
(−)-podophyllotoxin
(-)-Podophyllotoxin
6,7]NAPHTHO[2,3-D][1,3]DIOXOL-6(5AH)-ONE
9-HYDROXY-5-(3,4,5-TRIMETHOXYPHENYL)-5,8,8A,9-TETRAHYDROFURO[3',4'
9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one
Ardern brand OF podophyllotoxin
AXL-1717
AXL1717|podofilox
Canderm brand OF podophyllotoxin
Condyline
Condylox
CPH86
Epipodophyllotoxin
Fides ecopharma brand OF podophyllotoxin
Hamilton brand OF podophyllotoxin
Newport brand OF podophyllotoxin
NSC-24818
NSC-36407
Oclassen brand OF podophyllotoxin
Paddock brand OF podophyllotoxin
Paladin brand OF podophyllotoxin
|
PICROPODOPHYLLIN
PICROPODOPHYLLOTOXIN
PODOCON-25
Podofilm
Podofilox
Podophyllinate lactone
Podophyllinic acid lactone
Podophyllotoxin
Podophyllotoxin 7
PODOPHYLLOTOXIN PICROPODOPHYLLIN
Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 alpha))-isomer
Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 beta))-isomer
Podophyllotoxin, (5R-(5 alpha,5a alpha,8a beta,9 alpha))-isomer
Podophyllotoxin, (5R-(5 alpha,5a beta,8a alpha,9 beta))-isomer
PPT
Stiefel brand OF podophyllotoxin
Wartec
Warticon
Wolff brand OF podophyllotoxin
Yamanouchi brand OF podophyllotoxin
|
|
6 |
|
Prednisone |
Approved, Vet_approved |
Phase 2 |
|
53-03-2 |
5865 |
Synonyms:
1,2-Dehydrocortisone
1,4-Pregnadiene-17a,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17α,21-diol-3,11,20-trione
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
Acis brand OF prednisone
Acsis, prednison
Adasone
Ancortone
Apo-prednisone
Apotex brand OF prednisone
Aventis brand OF prednisone
Betapar
Bicortone
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
Cutason
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta-cortelan
Deltacortene
delta-Cortisone
Deltacortisone
Deltacortone
Delta-cortone
DELTA-DOME
Deltasone
Deltison
Deltisona
Deltisone
Deltra
Diadreson
Di-Adreson
Diba brand OF prednisone
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fawns and mcallan brand OF prednisone
FERNISONE
Ferring brand OF prednisone
Fiasone
GALENpharma brand OF prednisone
Halsey drug brand OF prednisone
Hexal brand OF prednisone
Hoechst brand OF prednisone
Hostacortin
ICN brand OF prednisone
Incocortyl
In-Sone
Juvason
Kortancyl
Lichtenstein brand OF prednisone
|
Liquid pred
Lisacort
LODOTRA
Lodotra®|Sterapred®
Me-Korti
Merck brand OF prednisone
Merz brand OF prednisone
Metacortandracin
Meticorten
Mibe brand OF prednisone
Nisona
Nizon
Novoprednisone
NSC-10023
Nurison
Orasone
Origen Prednisone
Panafcort
Panasol
PARACORT
Parmenison
Pehacort
Pharmacia brand OF prednisone
PRD
Precort
Predeltin
PREDN
Predni tablinen
PREDNICEN-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Predniment
Prednison
Prednison acsis
Prednison galen
Prednison hexal
Prednisona
Prednisona [INN-Spanish]
Prednisone
PREDNISONE INTENSOL
PREDNISONE TABLETS
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Pronison
Pronisone
RAYOS
Rectodelt
Retrocortine
Schering-plough brand OF prednisone
Seatrace brand OF prednisone
SERVISONE
Solvay brand OF prednisone
Sone
Sterapred
Supercortil
Trommsdorff brand OF prednisone
Ultracorten
Ultracortene
Winpred
Wojtab
Zenadrid
|
|
7 |
|
Cytarabine |
Approved, Investigational |
Phase 2 |
|
147-94-4 |
6253 |
Synonyms:
(beta-D-Arabinofuranosyl)cytosine
1-Arabinofuranosylcytosine
1-b-D-Arabinofuranosylcytosine
1beta -Arabinofuranasylcytosine
1-beta -D-Arabinofaranosylcytosine
1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone
1beta -D-Arabinofuranosylcytosine
1-beta -D-Arabinofuranosylcytosine
1beta -D-Arabinosylcytosine
1beta-Arabinofuranasylcytosine
1-beta-D-Arabinofaranosylcytosine
1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone
1beta-D-Arabinofuranosylcytosine
1-beta-D-Arabinofuranosylcytosine
1-beta-D-Arabinofuranosyl-cytosine
1-beta-D-Arabinofuranosylcytosine, cytosine arabinoside
1beta-D-Arabinosylcytosine
1-beta-D-Arabinosylcytosine
1-beta-D-Arabinosyl-cytosine
1-Î’-D-arabinofuranosylcytosine
2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl
4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin
4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine
4-Amino-1-b-D-arabinofuranosyl-2(1H)-pyrimidinone
4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone
4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone
4-Amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one
4-Amino-1-β-D-arabinofuranosyl-2(1H)-pyrimidinone
Alexan
ALEXAN 100
AR3
Ara C
Arabinocytidine
Arabinocytosine
Arabinofuranosylcytosine
Arabinoside C
Arabinoside, cytosine
ARABINOSYL CYTOSINE
Arabinosylcytosine
Arabitin
AraC
Ara-C
Aracytidine
ARA-CYTIDINE
Aracytin
Aracytine
Arafcyt
beta Ara C
beta -Arabinosylcytosine
beta -Cytosine arabinoside
beta -D-Arabinosylcytosine
beta-Ara c
|
beta-Arabinosylcytosine
beta-Cytosine arabinoside
beta-D-Arabinosylcytosine
Citarabina
Citarabina [INN-Spanish]
Cytarabin
Cytarabina
Cytarabine
Cytarabine hydrochloride
Cytarabine liposome
Cytarabine liposome injection
Cytarabinoside
Cytarabinum
Cytarabinum [INN-Latin]
Cytarbel
Cytonal
Cytosar
Cytosar u
Cytosar-u
CytosarU
Cytosine 1-beta-D-arabinofuranoside
Cytosine arabinofuranoside
Cytosine arabinose
Cytosine arabinoside
Cytosine beta-D-arabinofuranoside
Cytosine beta-D-arabinoside
Cytosine, beta -D-arabinoside
Cytosine, beta-D-arabinoside
Cytosine-1-b-D-arabinofuranoside
Cytosine-1-beta-D-arabinofuranoside
Cytosine-1-beta-D-arabinofuranoside hydrochloride
Cytosine-1-β-D-arabinofuranoside
Cytosinearabinoside
Cytosine-b-D-arabinofuranoside
Cytosine-beta -arabinoside
Cytosine-beta -D-arabinofuranoside
Cytosine-beta-arabinoside
Cytosine-beta-D-arabinofuranoside
Cytosine-β-D-arabinofuranoside
Depocyt
Depocyt (liposomal)
Depocyte
Erpalfa
Hydrochloride, cytarabine
Iretin
NSC-287459
Spongocytidine
Tarabine
TARABINE PFS
U-19920
Udicil
|
|
8 |
|
Mechlorethamine |
Approved, Investigational |
Phase 2 |
|
51-75-2 |
4033 |
Synonyms:
2,2'-Dichloro-N-methyldiethylamine
b,Beta'-dichlorodiethyl-N-methylamine
beta,Beta'-dichlorodiethyl-N-methylamine
BIS (2-CHLOROETHYL) METHYLAMINE
Bis(2-chloroethyl)methylamine
Bis(b-chloroethyl)methylamine
Bis(beta-chloroethyl)methylamine
Bis(β-chloroethyl)methylamine
Caryolysine
Chlorethazine
Chlormethine
Chlormethinum
Cloramin
Clormetina
Embichin
HN2
HN-2
Hydrochloride N-oxide, mechlorethamine
Hydrochloride, mechlorethamine
MBA
Mechlorethamine
Mechlorethamine hydrochloride
Mechlorethamine hydrochloride N oxide
Mechlorethamine hydrochloride N-oxide
Mechlorethamine N oxide
Mechlorethamine N-oxide
Mechlorethamine oxide
Mechloroethamine
Mecloretamina
|
Merck brand OF mechlorethamine hydrochloride
Merck frosst brand OF mechlorethamine hydrochloride
Methylbis(2-chloroethyl)amine
Methylbis(b-chloroethyl)amine
Methylbis(beta-chloroethyl)amine
Methylbis(β-chloroethyl)amine
Methylchlorethamine
Mitomen
Mustargen
Mustine
Nitrogen mustard
Nitrogen mustard N oxide
Nitrogen mustard N-oxide
NITROGEN MUSTARD N-OXIDE HYDROCHLORIDE
Nitrogranulogen
Nitromin
N-Methyl-bis(2-chloroethyl)amine
N-Methyl-bis(b-chloroethyl)amine
N-Methyl-bis(beta-chloroethyl)amine
N-Methyl-bis(β-chloroethyl)amine
N-Oxide, mechlorethamine hydrochloride
N-Oxide, nitrogen mustard
NSC 762
NSC-10107
NSC-128663
NSC-762
Î’,beta'-dichlorodiethyl-N-methylamine
β,β'-dichlorodiethyl-N-methylamine
|
|
9 |
|
D-Phenylalanine |
Approved, Experimental, Investigational, Nutraceutical |
Phase 2 |
|
63-91-2, 673-06-3 |
6140 71567 |
Synonyms:
(-)-beta-Phenylalanine
(6S)-Tetrahydrofolate
(6S)-Tetrahydrofolic acid
(6S)-THFA
(L)-Phenylalanine
(S)-(-)-Phenylalanine
(S)-2-Amino-3-phenylpropanoate
(S)-2-Amino-3-phenylpropanoic acid
(S)-2-Amino-3-phenylpropionate
(S)-2-AMINO-3-PHENYLPROPIONIC ACID
(S)-a-Amino-b-phenylpropionate
(S)-a-Amino-b-phenylpropionic acid
(S)-alpha-Aminobenzenepropanoate
(S)-alpha-Amino-benzenepropanoate
(S)-alpha-Aminobenzenepropanoic acid
(S)-alpha-Amino-benzenepropanoic acid
(S)-alpha-Amino-beta-phenylpropionate
(S)-ALPHA-AMINO-BETA-PHENYLPROPIONIC ACID
(S)-alpha-Aminohydrocinnamate
(S)-alpha-Aminohydrocinnamic acid
(S)-Phenylalanine
(S)-Α-amino-β-phenylpropionate
(S)-Α-amino-β-phenylpropionic acid
3-PHENYL-L-ALANINE
5,6,7,8-Tetrahydrofolate
5,6,7,8-Tetrahydrofolic acid
a-Amino-b-phenylpropionate
a-Amino-b-phenylpropionic acid
alpha-Amino-beta-phenylpropionate
alpha-Amino-beta-phenylpropionic acid
alpha-Aminohydrocinnamate
|
alpha-Aminohydrocinnamic acid
beta-Phenylalanine
beta-Phenyl-alpha-alanine
BETA-PHENYL-L-ALANINE
b-Phenyl-L-alanine
D-(+)-phenylalanine
DL-Phenylalanine
Endorphenyl
F
FEMA NO. 3585
Fenilalanina
L-2-Amino-3-phenylpropionate
L-2-Amino-3-phenylpropionic acid
L-Isomer phenylalanine
L-PHE
L-Phenylalanine
NSC-79477
PHE
Phenylalamine
Phenylalanin
Phenylalanine
Phenyl-alanine
Phenylalanine, L isomer
Phenylalanine, L-isomer
Phenylalaninum
Tetrahydrofolate
THF
Α-amino-β-phenylpropionate
Α-amino-β-phenylpropionic acid
Î’-PHENYL-L-ALANINE
|
|
10 |
|
Cortisone |
Experimental |
Phase 2 |
|
53-06-5 |
222786 |
Synonyms:
11-Dehydro-17-hydroxycorticosterone
17a,21-Dihydroxy-4-pregnene-3,11,20-trione
17alpha,21-Dihydroxy-4-pregnene-3,11,20-trione
17-Hydroxy-11-dehydrocorticosterone
17-Hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate
17Α,21-dihydroxy-4-pregnene-3,11,20-trione
4-Pregnene-17a,21-diol-3,11,20-trione
4-Pregnene-17alpha,21-diol-3,11,20-trione
4-Pregnene-17α,21-diol-3,11,20-trione
Adreson
Andreson
Anusol HC
Balneol-HC
beta-HC
Colocort
Compound e
Corlin
Cortadren
Cortandren
Cortef
Cortef acetate
Cortisal
Cortisate
Cortison
Cortisona
CORTISONE
Cortisone acetate
Cortisonum
Cortistal
Cortivite
Cortogen
Cortone
Cortone acetate
Cortril
delta(4)-Pregnene-17a,21-diol-3,11,20-trione
|
Delta(4)-Pregnene-17alpha,21-diol-3,11,20-trione
Dermacort
Dricort
Flexicort
Florinef
Fludrocortisone acetate
Glycort
Hemsol-HC
Hi-cor
Incortin
Kendall'S compound
Kendall's compound e
Kortison
Locoid
Locoid lipocream
Micort-HC
Nogenic HC
NSC-9703
Orabase hca
Pandel
Pregn-4-en-17a,21-diol-3,11,20-trione
Pregn-4-en-17alpha,21-diol-3,11,20-trione
Pregn-4-en-17α,21-diol-3,11,20-trione
Prestwick_132
Reichstein fa
Reichstein's substance fa
Scheroson
Solu-cortef
Stie-cort
Texacort
Westcort
Wintersteiner's compound F
Δ(4)-pregnene-17a,21-diol-3,11,20-trione
Δ(4)-pregnene-17α,21-diol-3,11,20-trione
|
|
11 |
|
Central Nervous System Stimulants |
|
Phase 1, Phase 2 |
|
|
|
12 |
|
Vasoconstrictor Agents |
|
Phase 1, Phase 2 |
|
|
|
13 |
|
Sympathomimetics |
|
Phase 1, Phase 2 |
|
|
|
14 |
|
Antineoplastic Agents, Hormonal |
|
Phase 2 |
|
|
|
15 |
|
Antiviral Agents |
|
Phase 2 |
|
|
|
16 |
|
Alkylating Agents |
|
Phase 2 |
|
|
|
17 |
|
Antineoplastic Agents, Alkylating |
|
Phase 2 |
|
|
|
18 |
|
Anti-Infective Agents |
|
Phase 2 |
|
|
|
19 |
|
Etoposide phosphate |
|
Phase 2 |
|
|
16760419 |
Synonyms:
{4-[16-({7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-D][1,3]dioxin-6-yl}oxy)-12-oxo-4,6,13-trioxatetracyclo[7.7.0.0,.0,]hexadeca-1,3(7),8-trien-10-yl]-2,6-dimethoxyphenoxy}phosphonate
BMY-40481
ETOPOPHOS
ETOPOPHOS PRESERVATIVE FREE
|
ETOPOSIDE PHOSPHATE
Etoposide phosphoric acid
VP16
VP-16
|
|
20 |
|
Antimitotic Agents |
|
Phase 2 |
|
|
|
21 |
|
Hormones |
|
Phase 2 |
|
|
|
22 |
|
Keratolytic Agents |
|
Phase 2 |
|
|
|
23 |
|
Nitrogen Mustard Compounds |
|
Phase 2 |
|
|
|
24 |
|
Hormone Antagonists |
|
Phase 2 |
|
|
|
25 |
|
Antimetabolites |
|
Phase 2 |
|
|
|
26 |
|
Antilymphocyte Serum |
|
Phase 2 |
|
|
|
27 |
|
Tubulin Modulators |
|
Phase 2 |
|
|
|
28 |
|
Thymoglobulin |
|
Phase 2 |
|
|
|
29 |
|
glucocorticoids |
|
Phase 2 |
|
|
|
30 |
|
Anti-Inflammatory Agents |
|
Phase 2 |
|
|
|
31 |
|
Dermatologic Agents |
|
Phase 2 |
|
|
|
32 |
|
Immunosuppressive Agents |
|
Phase 2 |
|
|
|
33 |
|
Immunologic Factors |
|
Phase 2 |
|
|
|
34 |
|
D-Alanine |
Experimental, Nutraceutical |
Phase 2 |
|
302-72-7, 338-69-2, 56-41-7 |
101757026 602 71080 5950 |
Synonyms:
(2R)-2-Aminopropanoate
(2R)-2-Aminopropanoic acid
(2R)-2-Aminopropionic acid
(2S)-2-Aminopropanoate
(2S)-2-AMINOPROPANOIC ACID
(a-D-Mannosyl)7-b-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform a (protein)
(R)-2-Aminopropanoate
(R)-2-Aminopropanoic acid
(R)-2-Aminopropionic acid
(R)-Alanine
(S)-(+)-Alanine
(S)-2-Aminopropanoate
(S)-2-Amino-propanoate
(S)-2-Amino-propanoic acid
(S)-2-AMINOPROPANOIC ACID
(S)-ALANINE
(Α-D-mannosyl)7-β-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform a (protein)
[<sup>14</sup>C]-alanine
[<sup>3</sup>H]-alanine
2-Aminopropanoate
2-Aminopropanoic acid
2-Aminopropionate
2-Aminopropionic acid
2-Ammoniopropanoate
2-Ammoniopropanoic acid
A
a-Alanine
a-Aminopropionate
a-Aminopropionic acid
Abufène
ALA
Alanin
Alanina
Alanine
Alanine doms-adrian brand
Alanine, L isomer
Alanine, L-isomer
Alaninum
alpha-Alanine
alpha-Aminopropanoate
alpha-Aminopropanoic acid
alpha-Aminopropionate
|
alpha-Aminopropionic acid
D(-)-a -Alanine
D-(-)-Alanine
D(-)-alpha-Alanine
D(-)-Α-alanine
D-2-Aminopropionate
D-2-Aminopropionic acid
D-a-Alanine
D-a-Aminopropionate
D-a-Aminopropionic acid
DAL
D-Ala
D-Alanin
D-ALANINE
D-alpha-Alanine
D-alpha-Aminopropionate
D-alpha-Aminopropionic acid
Doms adrian brand OF alanine
Doms-adrian brand OF alanine
D-Α-alanine
D-Α-aminopropionate
D-Α-aminopropionic acid
E639
Ellagate arabinoside
L Alanine
L-(+)-Alanine
L-2-Aminopropanoate
L-2-Aminopropanoic acid
L-2-Aminopropionate
L-2-AMINOPROPIONIC ACID
L-a-Alanine
L-a-Aminopropionate
L-a-Aminopropionic acid
L-ALA
L-Alanin
L-Alanine
L-ALPHA-ALANINE
L-alpha-Aminopropionate
L-alpha-Aminopropionic acid
L-Isomer alanine
L-Α-ALANINE
NSC-206315
|
|
35 |
|
Salbutamol |
Approved, Vet_approved |
Phase 1 |
|
18559-94-9 |
2083 |
Synonyms:
(±)-SALBUTAMOL
(L)-Albuterol
1-(Tert-butylaminomethyl)-4-hydroxy-m-xylene-alpha1,alpha3-diol
2-(Tert-butylamino)-1-(4-hydroxy-3-hydroxymethylphenyl)ethanol
2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol
4-Hydroxy-3-hydroxymethyl-alpha-((tert-butylamino)methyl)benzyl alcohol
ACCUNEB
Aerolin
AEROLIN 400
AEROLIN AUTO
AIROMIR
AIRSALB
Albuterol
Albuterol sulfate
Albuterol Sulphate
albuterol|SCH-13949W|Ventolin®
Almotex
Alpha'-((tert-butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol
Alti-salbutamol
Anebron
Arubendol-salbutamol
Asmadil
Asmanil
Asmasal
ASMASAL CLICKHALER
ASMASAL SPACEHALER
Asmatol
Asmaven
ASMAVENT
Asmidon
Asmol
Asmol uni-dose
Asthalin
Asthavent
Broncho-spray
Broncovaleas
Bronter
BTA204
Bugonol
Bumol
Butamol
Buto-asma
Butohaler
Butotal
Butovent
Buventol
Cetsim
Cobutolin
COMBIVENT
COMBIVENT UDVS
Dilatamol
DL-Albuterol
DL-N-Tert-butyl-2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethylamine
DL-Salbutamol
DUONEB
Ecovent
Farcolin
Gerivent
Grafalin
IPRAMOL STERI-NEB
KENTAMOL
Levalbuterol
LIBETIST
Libretin
Loftan
MAXIVENT
Medolin
Mozal
Novosalmol
Parasma
Pneumolat
ProAir
PROAIR HFA
Proventil
|
Proventil hfa
Proventil inhaler
PROVENTIL-HFA
Respax
Respolin
RIMASAL
Rotahaler
R-Salbutamol
Sabutal
Salamol
SALAMOL E-BREATHE
SALAPIN
Salbetol
Salbron
Salbu-basf
Salbu-fatol
Salbuhexal
Salbulin
SALBULIN NOVOLIZER
Salbupur
Salbusian
Salbutalan
SALBUTAMOL
Salbutamol free base
Salbutamol sulfate
Salbutamol sulphate
Salbutamolum
Salbutan
Salbutard
Salbutine
Salbutol
Salbuven
Salbuvent
SALIPRANEB
Sallbupp
Salmaplon
Salomol
Salvent
Saventol
SCH 13949W
SCH-13949W
Servitamol
Solbutamol
Spreor
STERI-NEB SALAMOL
Sultanol
Sultanol N
Suprasma
Suxar
Theosal
Tobybron
Vencronyl
Venetlin
Ventalin Inhaler
Ventamol
Ventilan
Ventiloboi
VENTMAX SR
Ventodisks
Ventolin
VENTOLIN CR
VENTOLIN E-BREATHE
VENTOLIN HFA
Ventolin inhaler
Ventolin rotacaps
Ventoline
Volare albuterol hfa
Volare easi-breathe
Volma
Volmax
Xopenex
Xopenex HFA
Zaperin
|
|
36 |
|
Adrenergic Agents |
|
Phase 1 |
|
|
|
37 |
|
Neurotransmitter Agents |
|
Phase 1 |
|
|
|
38 |
|
Bronchodilator Agents |
|
Phase 1 |
|
|
|
39 |
|
Adrenergic beta-Agonists |
|
Phase 1 |
|
|
|
40 |
|
Adrenergic Agonists |
|
Phase 1 |
|
|
|
41 |
|
Anti-Asthmatic Agents |
|
Phase 1 |
|
|
|
42 |
|
Respiratory System Agents |
|
Phase 1 |
|
|
|
43 |
|
Tocolytic Agents |
|
Phase 1 |
|
|
|
44 |
|
Amifampridine |
Approved, Investigational |
|
|
54-96-6 |
5918 |
Synonyms:
3,4 Diaminopyridine
3,4-DAP
3,4-Diaminopyridine
3,4-DIAMMONIOPYRIDINIUM
3,4-Pyridinediamine
4,5-Diaminopyridine
4-DAP
Amifampridine
|
Amifampridine phosphate
DAP
Firdapse
NSC-521760
PYRIDINE-3,4-DIAMINE
Ruzurgi
ZENAS
|
|
45 |
|
Potassium Channel Blockers |
|
|
|
|
|
Interventional clinical trials:
(show all 24)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Phase 3, Double-Blind, Placebo-controlled, Randomized, Parallel-Group Study to Evaluate the Efficacy and Safety of Amifampridine Phosphate in Patients With Lambert-Eaton Myasthenic Syndrome |
Completed |
NCT02970162 |
Phase 3 |
Amifampridine Phosphate;Placebo Oral Tablet |
2 |
A Phase 3, Double-blind, Placebo-controlled, Randomized Discontinuation Study Followed by Open-label Extension Evaluating Efficacy and Safety of Amifampridine Phosphate in Patients With Lambert-Eaton Myasthenic Syndrome (LEMS) |
Completed |
NCT01377922 |
Phase 3 |
Amifampridine Phosphate;Placebo |
3 |
A Phase 3, Double-blind, Outpatient Crossover Study to Evaluate the Efficacy and Safety of Amifampridine Phosphate (3,4 Diaminopyridine Phosphate) in Patients With Congenital Myasthenic Syndromes (CMS) |
Completed |
NCT02562066 |
Phase 3 |
amifampridine phosphate;Placebo |
4 |
Ephedrine for the Treatment of Congenital Myasthenia |
Unknown status |
NCT00541216 |
Phase 1, Phase 2 |
Ephedrine |
5 |
Inpatient Double-Blind Placebo-Controlled Withdrawal Study of 3,4-Diaminopyridine Base (3,4-DAP) in Subjects With Known Lambert-Eaton Myasthenic Syndrome |
Completed |
NCT01511978 |
Phase 2 |
Continuous 3,4-DAP;Taper 3,4-DAP to Placebo |
6 |
High-Dose Immunosuppressive Therapy Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) + Thymoglobulin Followed by Syngeneic or Autologous Hematopoietic Cell Transplantation for Patients With Autoimmune Neurologic Diseases |
Recruiting |
NCT00716066 |
Phase 2 |
Carmustine;Cytarabine;Etoposide;Melphalan;Prednisone |
7 |
Controlled Trial of 3,4-Diaminopyridine in LEMS |
Terminated |
NCT02090725 |
Phase 2 |
3-4 Diaminopyridine |
8 |
Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes |
Completed |
NCT01203592 |
Phase 1 |
Albuterol |
9 |
National Registry for Egyptian Pediatric Neuromuscular Diseases |
Unknown status |
NCT02124616 |
|
|
10 |
Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection: Consequences on the Severity of Myasthenic Syndrome and Reciprocal Impact of the Two Pathologies on Their Respective Treatments |
Unknown status |
NCT04695379 |
|
|
11 |
Open Label Trial Of 3,4-Diaminopyridine In Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenic Syndromes (CMS) |
Approved for marketing |
NCT00872950 |
|
3,4-DIAMINOPYRIDINE |
12 |
Use of 3,4-Diaminopyridine(3 4-DAP)in the Treatment of Lambert-Eaton Syndrome (LEMS) |
Approved for marketing |
NCT01825395 |
|
3, 4-Diaminopyridine |
13 |
Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome |
Completed |
NCT00004832 |
|
3,4-diaminopyridine |
14 |
Barriers and Facilitators to Exercise for Individuals With Autoimmune Myasthenia Gravis, Congenital Myasthenic Syndrome or Lambert-Eaton Myasthenic Syndrome in France: a Descriptive, Cross-sectional Study |
Completed |
NCT05408702 |
|
|
15 |
Retrospective Study :Describe the Changes of the Disease in Many Cases Likely to Aggravate. |
Completed |
NCT01474980 |
|
|
16 |
Congenital Muscle Disease Patient and Proxy Reported Outcome Study |
Recruiting |
NCT01403402 |
|
|
17 |
Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia |
Available |
NCT03062631 |
|
3,4-Diaminopyridine |
18 |
3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome and Congenital Myasthenia |
No longer available |
NCT02012933 |
|
3,4-diaminopyridine |
19 |
Treatment of Lambert-Eaton Myasthenic Syndrome and Congenital Myasthenic Syndromes With 3, 4-Diaminopyridine |
No longer available |
NCT01378546 |
|
3,4-diaminopyridine |
20 |
Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome |
No longer available |
NCT01373333 |
|
3,4 DAP |
21 |
Treatment of Lambert-Eaton Syndrome With 3, 4-Diaminopyridine |
No longer available |
NCT00704925 |
|
3, 4 DAP |
22 |
Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine |
No longer available |
NCT00994916 |
|
3,4 diaminopyridine |
23 |
An Open-Label, Expanded Access Protocol for Amifampridine Phosphate Treatment in Patients With Congenital Myasthenic Syndrome (CMS) |
No longer available |
NCT02189720 |
|
Amifampridine Phosphate |
24 |
Treatment Use of 3,4-Diaminopyridine in Congenital Myasthenic Syndrome |
No longer available |
NCT01765140 |
|
3,4-diaminopyridine |
|